vs
Ally Financial Inc.（ALLY）与Ascendis Pharma A/S（ASND）财务数据对比。点击上方公司名可切换其他公司
Ally Financial Inc.的季度营收约是Ascendis Pharma A/S的1.1倍（$301.0M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs -3.2%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 11.1%）
Ally Financial Inc.是注册于美国特拉华州、总部位于密歇根州底特律的银行控股企业，业务覆盖汽车金融、直营银行线上服务、企业贷款、车辆保险、住房抵押贷款，以及分期销售、租赁协议等相关配套融资服务。
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
ALLY vs ASND — 直观对比
营收规模更大
ALLY
是对方的1.1倍
$267.3M
营收增速更快
ASND
高出45.5%
-3.2%
两年增速更快
ASND
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $301.0M | $267.3M |
| 净利润 | $327.0M | — |
| 毛利率 | — | 90.5% |
| 营业利润率 | — | — |
| 净利率 | 108.6% | — |
| 营收同比 | -3.2% | 42.3% |
| 净利润同比 | 333.6% | — |
| 每股收益（稀释后） | $0.97 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALLYASND
| Q4 25 | $301.0M | $267.3M | ||
| Q3 25 | $308.0M | $230.7M | ||
| Q2 25 | $312.0M | $170.7M | ||
| Q1 25 | $323.0M | $109.0M | ||
| Q4 24 | $311.0M | $187.8M | ||
| Q3 24 | $319.0M | $62.5M | ||
| Q2 24 | $324.0M | $38.9M | ||
| Q1 24 | $244.0M | $103.6M |
净利润ALLYASND
| Q4 25 | $327.0M | — | ||
| Q3 25 | $398.0M | $-65.9M | ||
| Q2 25 | $352.0M | $-42.0M | ||
| Q1 25 | $-225.0M | $-102.2M | ||
| Q4 24 | $-140.0M | — | ||
| Q3 24 | $357.0M | $-107.1M | ||
| Q2 24 | $294.0M | $-118.1M | ||
| Q1 24 | $157.0M | $-141.5M |
毛利率ALLYASND
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 89.5% | ||
| Q2 25 | — | 80.1% | ||
| Q1 25 | — | 82.6% | ||
| Q4 24 | — | 91.9% | ||
| Q3 24 | — | 80.6% | ||
| Q2 24 | — | 68.2% | ||
| Q1 24 | — | 92.1% |
营业利润率ALLYASND
| Q4 25 | — | — | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | -33.5% | ||
| Q1 25 | -87.9% | -103.2% | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 73.0% | -167.3% | ||
| Q2 24 | 79.3% | -370.2% | ||
| Q1 24 | 70.1% | -51.2% |
净利率ALLYASND
| Q4 25 | 108.6% | — | ||
| Q3 25 | 129.2% | -28.5% | ||
| Q2 25 | 112.8% | -24.6% | ||
| Q1 25 | -69.7% | -93.7% | ||
| Q4 24 | -45.0% | — | ||
| Q3 24 | 111.9% | -171.5% | ||
| Q2 24 | 90.7% | -303.9% | ||
| Q1 24 | 64.3% | -136.6% |
每股收益（稀释后）ALLYASND
| Q4 25 | $0.97 | — | ||
| Q3 25 | $1.18 | — | ||
| Q2 25 | $1.04 | — | ||
| Q1 25 | $-0.82 | — | ||
| Q4 24 | $-0.54 | — | ||
| Q3 24 | $1.06 | — | ||
| Q2 24 | $0.86 | — | ||
| Q1 24 | $0.42 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.0B | $665.3M |
| 总债务越低越好 | $17.1B | — |
| 股东权益账面价值 | $15.5B | $-175.8M |
| 总资产 | $196.0B | $1.4B |
| 负债/权益比越低杠杆越低 | 1.10× | — |
8季度趋势，按日历期对齐
现金及短期投资ALLYASND
| Q4 25 | $10.0B | $665.3M | ||
| Q3 25 | $10.2B | $582.2M | ||
| Q2 25 | $10.6B | $533.6M | ||
| Q1 25 | $10.4B | $559.4M | ||
| Q4 24 | $10.3B | $604.3M | ||
| Q3 24 | $8.6B | $675.6M | ||
| Q2 24 | $7.4B | $279.4M | ||
| Q1 24 | $8.2B | $345.9M |
总债务ALLYASND
| Q4 25 | $17.1B | — | ||
| Q3 25 | $16.7B | — | ||
| Q2 25 | $15.9B | — | ||
| Q1 25 | $16.5B | — | ||
| Q4 24 | $17.5B | — | ||
| Q3 24 | $16.8B | — | ||
| Q2 24 | $16.0B | — | ||
| Q1 24 | $17.0B | — |
股东权益ALLYASND
| Q4 25 | $15.5B | $-175.8M | ||
| Q3 25 | $15.1B | $-188.0M | ||
| Q2 25 | $14.5B | $-202.6M | ||
| Q1 25 | $14.2B | $-205.0M | ||
| Q4 24 | $13.9B | $-114.2M | ||
| Q3 24 | $14.7B | $-105.1M | ||
| Q2 24 | $13.9B | $-346.8M | ||
| Q1 24 | $13.7B | $-257.2M |
总资产ALLYASND
| Q4 25 | $196.0B | $1.4B | ||
| Q3 25 | $191.7B | $1.2B | ||
| Q2 25 | $189.5B | $1.2B | ||
| Q1 25 | $193.3B | $1.1B | ||
| Q4 24 | $191.8B | $1.3B | ||
| Q3 24 | $193.0B | $1.2B | ||
| Q2 24 | $192.5B | $819.0M | ||
| Q1 24 | $192.9B | $866.7M |
负债/权益比ALLYASND
| Q4 25 | 1.10× | — | ||
| Q3 25 | 1.11× | — | ||
| Q2 25 | 1.09× | — | ||
| Q1 25 | 1.16× | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 1.14× | — | ||
| Q2 24 | 1.15× | — | ||
| Q1 24 | 1.25× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $640.0M | $58.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.96× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALLYASND
| Q4 25 | $640.0M | $58.2M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $947.0M | — | ||
| Q1 25 | $940.0M | $-15.5M | ||
| Q4 24 | $620.0M | $-330.7M | ||
| Q3 24 | $992.0M | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.3B | $-109.7M |
现金转化率ALLYASND
| Q4 25 | 1.96× | — | ||
| Q3 25 | 3.02× | — | ||
| Q2 25 | 2.69× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.78× | — | ||
| Q2 24 | 5.36× | — | ||
| Q1 24 | 8.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALLY
| Noninsurance Contracts | $242.0M | 80% |
| Brokerage Commissionsand Other | $21.0M | 7% |
| Commercial Portfolio Segment | $19.0M | 6% |
| Other | $13.0M | 4% |
| Banking Fees And Interchange Income | $5.0M | 2% |
| Brokered Agent Commissions | $1.0M | 0% |
ASND
暂无分部数据
